This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Tel Aviv University, Other. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 846 
1 out of 834,708 Years Active: 2009-2014
Title: Alexander Battler: Innovator in Angiogenesis Research
Introduction
Alexander Battler is a notable inventor based in Ramat-Hasharon, Israel. He has made significant contributions to the field of angiogenesis research, holding a total of 3 patents. His work focuses on developing compositions and methods that can induce angiogenesis, which is crucial for treating various pathologies.
Latest Patents
Among his latest patents, Battler has developed an isolated peptide comprising an amino acid sequence HWRR, as set forth by SEQ ID NO:5. This peptide, consisting of 4 or 5 amino acids, is designed to induce angiogenesis. The patent also includes methods for treating angiogenesis-related pathologies using this peptide or pharmaceutical compositions that incorporate it.
Career Highlights
Throughout his career, Alexander Battler has worked with prestigious institutions, including Tel Aviv University. His research has contributed to advancements in medical treatments related to angiogenesis.
Collaborations
Battler has collaborated with notable individuals in his field, including Britta Hardy and Annat Raiter. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Alexander Battler's work in angiogenesis research exemplifies the impact of innovative thinking in medical science. His patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile